Literature DB >> 22332465

Negotiating hospital infections: the debate between ecological balance and eradication strategies in British hospitals, 1947-1969.

Flurin Condrau1, Robert G W Kirk.   

Abstract

This paper reviews and contrasts two strategies of infection control that emerged in response to the growing use of antibiotics within British hospitals, c. 1946-1969. At this time, we argue, the hospital became an arena within which representatives of the medical sciences and clinical practices contested not so much the content of knowledge but the way that knowledge translated into practice. Key to our story are the conceptual assumptions about antibiotics put forward by clinicians, on the one hand, and microbiologists on the other. The former embraced antibiotics as the latest weapon in their fight to eradicate disease. For clinicians, the use of antibiotics were utilised within a conceptual frame that prioritised the value of the individual patient before them. Microbiologists, in contrast, understood antibiotics quite differently. They adopted a complex understanding of the way antibiotics functioned within the hospital environment that emphasised the relational and ecological aspects of their use. Despite their broader environmental focus, microbiologists focus on the ways in which bacteria travelled led to ever greater emphasis to be placed on the "healthy" body which, having been exposed to antibiotics, became a dangerous carrier of resistant staphylococcal strains. The surrounding debate regarding the appropriate use of antibiotics reveals the complex relationship between hospital, the medical sciences and clinical practice. We conclude that the history of hospital infections invites a more fundamental reflection on global hospital cultures, antibiotic prescription practices, and the fostering of an interdisciplinary spirit among the professional groups living and working in the hospital.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22332465      PMCID: PMC3302197          DOI: 10.4321/s0211-95362011000200007

Source DB:  PubMed          Journal:  Dynamis        ISSN: 0211-9536            Impact factor:   0.429


  41 in total

1.  The role of the carrier in staphylococcal disease.

Authors:  K G GREEN
Journal:  Lancet       Date:  1961-10-21       Impact factor: 79.321

2.  Perineal carriage of Staph. aureus.

Authors:  M RIDLEY
Journal:  Br Med J       Date:  1959-01-31

3.  Invisible enemies: bacteriology and the language of politics in imperial Germany.

Authors:  C Gradmann
Journal:  Sci Context       Date:  2000       Impact factor: 0.425

4.  Staphylococcus pyogenes cross-infection; prevention by treatment of carriers.

Authors:  J C GOULD; W S ALLAN
Journal:  Lancet       Date:  1954-11-13       Impact factor: 79.321

5.  The "hospital superbug": social representations of MRSA.

Authors:  Peter Washer; Helene Joffe
Journal:  Soc Sci Med       Date:  2006-06-19       Impact factor: 4.634

Review 6.  Hospital infection: the first 2500 years.

Authors:  S Selwyn
Journal:  J Hosp Infect       Date:  1991-06       Impact factor: 3.926

7.  Infection by penicillin-resistant staphylococci.

Authors:  M BARBER; M ROZWADOWSKA-DOWZENKO
Journal:  Lancet       Date:  1948-10-23       Impact factor: 79.321

8.  Sycosis barbae; serological types of Staphylococcus pyogenes in nose and skin and results of penicillin treatment.

Authors:  B C HOBBS; H L CARRUTHERS; J GOUGH
Journal:  Lancet       Date:  1947-10-18       Impact factor: 79.321

9.  Puerperal fever, the streptococcus, and the sulphonamides, 1911-1945.

Authors:  I Loudon
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22

10.  The changing management of acute bronchitis in Britain, 1940-1970: the impact of antibiotics.

Authors:  John T Macfarlane; Michael Worboys
Journal:  Med Hist       Date:  2008-01       Impact factor: 1.419

View more
  1 in total

1.  Re-Inventing Infectious Disease: Antibiotic Resistance and Drug Development at the Bayer Company 1945-80.

Authors:  Christoph Gradmann
Journal:  Med Hist       Date:  2016-04       Impact factor: 1.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.